Disease activity in systemic lupus erythematosus patients with end-stage renal disease: Systematic review of the literature

Clinical Rheumatology

Volumn 31, Issue 6, 2012, Pages 897-905

  Mattos, Patrícia ^a   Santiago, Mittermayer B ^a,b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b SER Serviços Especializados em Reumatologia da Bahia   (Brazil)

Author keywords

Disease activity; End stage renal disease; Lupus flare; Renal replacement therapy; Systemic lupus erythematosus

Indexed keywords

CLINICAL ASSESSMENT; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; RECURRENT DISEASE; RENAL REPLACEMENT THERAPY; REVIEW; SERODIAGNOSIS; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; RHEUMATOLOGY; TIME FACTORS;

EID: 84863716263     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-1957-9     Document Type: Review

References (36)

1. von Feldt JM (1995) Systemic lupus erythematosus. Recognizing its various presentations. Postgrad Med 97(4):79, 83, 86
2. Liang CC, Huang CC, Wang IK, Chang CT, Chen KH, Weng CH et al (2010) Impact of renal survival on the course and outcome of systemic lupus erythematosus patients treated with chronic peritoneal dialysis. Ther Apher Dial 14(1):35-42
3. Mojcik CF, Klippel JH (1996) End-stage renal disease and systemic lupus erythematosus. Am J Med 101(1):100-107
4. Nossent HC, Swaak TJ, Berden JH (1990) Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch Working Party on SLE. Am J Med 89 (2):169-174
5. Wallace DJ, Podell TE, Weiner JM, Cox MB, Klinenberg JR, Forouzesh S et al (1982) Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980. Am J Med 72 (2):209-220
6. Brown CD, Rao TKS, Maxey RW, Butt KMH, Friedman EA (1979) Regression of clinical and immunological expression of systemic lupus erythematosus (SLE) consequent to development of uremia. Kidney Int 16:884
7. Cheigh JS, Stenzel KH, Rubin AL, Chami J, Sullivan JF (1983) Systemic lupus erythematosus in patients with chronic renal failure. Am J Med 75(4):602-606
8. Cheigh JS, Kim H, Stenzel KH, Tapia L, Sullivan JF, Stubenbord Wet al (1990) Systemic lupus erythematosus in patients with endstage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity. Am J Kidney Dis 16 (3):189-195
9. Coplon N, Siegel R, Fries J (1973) Hemodialysis on end-stage lupus nephritis. Trans Am Soc Artif Intern Organs 19:302-304
10. Coplon NS, Diskin CJ, Petersen J, Swenson RS (1983) The longterm clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med 308(4):186-190
11. Correia P, Cameron JS, Ogg CS, Williams DG, Bewick M, Hicks JA (1984) End-stage renal failure in systemic lupus erythematosus with nephritis. Clin Nephrol 22(6):293-302
12. Fries JF, Powers R, Kempson RL (1974) Late-stage lupus nephropathy. J Rheumatol 1(2):166-175
13. Jarrett MP, Santhanam S, Del GF (1983) The clinical course of end-stage renal disease in systemic lupus erythematosus. Arch Intern Med 143(7):1353-1356
14. Kang SH, Chung BH, Choi SR, Lee JY, Park HS, Sun IO et al (2011) Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis. Korean J Intern Med 26(1):60-67
15. Kimberly RP, Lockshin MD, Sherman RL, Beary JF, Mouradian J, Cheigh JS (1981) "End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients. Medicine (Baltimore) 60(4):277-287
16. Kobayashi M, Iitsuka T, Ishizu T, Hirayama K, Igarashi M, Yamaguchi N et al (1995) Clinicopathological study of dialysis patients with lupus nephritis. Nihon Jinzo Gakkai Shi 37 (8):456-461
17. Lee PT, Fang HC, Chen CL, Chiou YH, Chou KJ, Chung HM (2003) Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients. Lupus 12 (11):827-832
18. Okano K, Yumura W, Nitta K, Uchida K, Ohnuki T, Kawashima A et al (2001) Analysis of lupus activity in end-stage renal disease treated by hemodialysis. Intern Med 40(7):598-602
19. Szeto CC, Li PK, Wong TY, Leung CB, Lui SF (1998) Factors associated with active systemic lupus erythematosus after endstage renal disease. J Rheumatol 25(8):1520-1525
20. Ribeiro FM, Leite MA, Velarde GC, Fabris CL, Santos RC, Lugon JR (2005) Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort. Am J Nephrol 25(6):596-603
21. Bruce IN, Hallett DC, Gladman DD, Urowitz MB (1999) Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy. J Rheumatol 26(7):1490-1494
22. Goo YS, Park HC, Choi HY, Kim BS, Park YB, Lee SK et al (2004) The evolution of lupus activity among patients with endstage renal disease secondary to lupus nephritis. Yonsei Med J 45 (2):199-206
23. Krane NK, Burjak K, Archie M, O'donovan R (1999) Persistent lupus activity in end-stage renal disease. Am J Kidney Dis 33 (5):872-879
24. Pahl MV, Vaziri ND, Saiki JK, Upham T, Ness R (1984) Chronic hemodialysis in end-stage lupus nephritis: changes of clinical and serological activities. Artif Organs 8(4):423-428
25. Rodby RA, Korbet SM, Lewis EJ (1987) Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis. Am J Med 83(4):613-618
26. Sires RL, Adler SG, Louie JS, Cohen AH (1989) Poor prognosis in end-stage lupus nephritis due to nonautologous vascular access site associated septicemia and lupus flares. Am J Nephrol 9 (4):279-284
27. Siu YP, Leung KT, Tong MK, Kwan TH, Mok CC (2005) Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 20(12):2797-2802
28. Stock GG Jr, Krane NK (1993) Treatment of end-stage renal disease due to lupus nephritis: comparison of six patients treated with both peritoneal and hemodialysis. Adv Perit Dial 9:147-151
29. Kaul H, Girndt M, Sester U, Sester M, Kohler H (2000) Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease. Am J Kidney Dis 35 (4):611-616
30. Holdsworth SR, Fitzgerald MG, Hosking CS, Atkins RC (1978) The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis. Clin Exp Immunol 33(1):95-101
31. Kauffman CA, Manzler AD, Phair JP (1975) Cell-mediated immunity in patients on long-term haemodialysis. Clin Exp Immunol 22(1):54-61
32. Austin HA III, Boumpas DT, Vaughan EM, Balow JE (1994) Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 45(2):544-550
33. Barr RG, Seliger S, Appel GB, Zuniga R, D'Agati V, Salmon J et al (2003) Prognosis in proliferative lupus nephritis: the role of socioeconomic status and race/ethnicity. Nephrol Dial Transplant 18 (10):2039-2046
34. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M (1991) Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 91(4):345-353
35. Ward MM, Studenski S (1990) Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 150(4):849-853
36. Broder A, Khattri S, Patel R, Putterman C (2011) Undertreatment of disease activity in systemic lupus erythematosus patients with endstage renal failure is associated with increased all-cause mortality. J Rheumatol 38(11):2382-2389